Top companies in the world by Price to Sales Ratio (P/S)

This ranking features the top 22,433 companies in the world ranked by Price to Sales Ratio (P/S), averaging a Price to Sales Ratio (P/S) of 8,346.82, for January 15, 2025.

Global

All sectors

#	Name	Price to Sales Ratio (P/S)	Reported Date	Stock Price	Change	Country
1	Inhibikase Therapeutics, Inc. 1 IKT	184,503,984.00	Jan. 14, 2025	USD 2.66	NA	United States
2	Molecure S.A. 2 MOC.WA	1,481,732.57	Jan. 14, 2025	USD 2.23	1.07%	Poland
3	De Grey Mining Limited 3 DEG.AX	188,735.58	Jan. 14, 2025	USD 1.23	1.78%	Australia
4	Genomtec S.A. 4 GMT.WA	91,280.05	Jan. 14, 2025	USD 1.74	1.31%	Poland
5	Gatos Silver, Inc. 5 GATO	73,737.44	Jan. 14, 2025	USD 14.86	5.02%	United States
6	Deep Yellow Limited 6 DYL.AX	70,488.38	Jan. 14, 2025	USD 0.79	2.67%	Australia
7	LQwD FinTech Corp. 7 LQWD.V	60,971.89	Jan. 14, 2025	USD 1.23	13.06%	Canada
8	BrightPath Biotherapeutics Co., Ltd. 8 4594.T	48,782.23	Jan. 14, 2025	USD 0.27	-4.62%	Japan
9	NanoGroup S.A. 9 NNG.WA	43,209.58	Jan. 14, 2025	USD 0.79	1.05%	Poland
10	Benitec Biopharma Inc. 10 BNTC	40,164.37	Jan. 14, 2025	USD 10.38	-0.10%	United States
11	Pantheon Resources Plc 11 PANR.L	38,893.10	Jan. 14, 2025	USD 0.46	3.83%	United Kingdom
12	Compagnie du Cambodge 12 CBDG.PA	33,019.61	Jan. 14, 2025	USD 120.07	1.48%	France
13	Eco (Atlantic) Oil & Gas Ltd. 13 ECO.L	32,869.28	Jan. 14, 2025	USD 0.15	1.75%	Canada
14	Greenwich LifeSciences, Inc. 14 GLSI	29,258.97	Jan. 14, 2025	USD 12.06	-1.63%	United States
15	DatChat, Inc. 15 DATS	28,515.59	Jan. 14, 2025	USD 4.88	-9.96%	United States
16	Gigante Salmon AS 16 GIGA.OL	21,291.88	Jan. 14, 2025	USD 0.73	0.44%	Norway
17	OncoZenge AB (publ) 17 ONCOZ.ST	17,623.20	Jan. 14, 2025	USD 0.45	23.08%	Sweden
18	Forte Biosciences, Inc. 18 FBRX	15,578.39	Jan. 14, 2025	USD 14.62	-8.62%	United States
19	Diamyd Medical AB (publ) 19 DMYD-B.ST	13,325.69	Jan. 14, 2025	USD 1.61	0.34%	Sweden
20	Immix Biopharma, Inc. 20 IMMX	11,499.83	Jan. 14, 2025	USD 2.00	-5.66%	United States
21	Diamond Biofund Inc. 21 6901.TW	10,657.89	Jan. 14, 2025	USD 0.92	1.12%
22	Bullfrog AI Holdings, Inc. Common Stock 22 BFRG	10,613.47	Jan. 14, 2025	USD 2.10	-0.47%	United States
23	Cadrenal Therapeutics, Inc. Common Stock 23 CVKD	10,296.97	Jan. 14, 2025	USD 15.99	NA	United States
24	Revolution Medicines, Inc. 24 RVMD	9,919.66	Jan. 14, 2025	USD 39.83	-6.44%	United States
25	Allogene Therapeutics, Inc. 25 ALLO	9,362.10	Jan. 14, 2025	USD 1.92	-1.54%	United States
26	Viking Therapeutics, Inc. 26 VKTX	8,672.07	Jan. 14, 2025	USD 33.93	-12.73%	United States
27	Altimmune, Inc. 27 ALT	8,521.27	Jan. 14, 2025	USD 6.23	-8.11%	United States
28	Hemisphere Properties India Limited 28 HEMIPROP.NS	8,103.71	Jan. 14, 2025	USD 1.77	3.39%	India
29	NRx Pharmaceuticals, Inc. 29 NRXP	7,709.99	Jan. 14, 2025	USD 5.10	3.87%	United States
30	Infant Bacterial Therapeutics AB (publ) 30 IBT-B.ST	7,217.70	Jan. 14, 2025	USD 4.07	-5.72%	Sweden
31	Yaari Digital Integrated Services Limited 31 YAARI.NS	6,267.56	Jan. 14, 2025	USD 0.16	-4.92%	India
32	FunPep Company Limited 32 4881.T	6,112.67	Jan. 14, 2025	USD 0.87	-0.91%	Japan
33	Atreyu Capital Markets Ltd 33 ATRY.TA	5,719.92	Jan. 14, 2025	USD 20.97	1.77%	Israel
34	Joby Aviation, Inc. 34 JOBY	5,403.03	Jan. 14, 2025	USD 7.86	-1.26%	United States
35	Akero Therapeutics, Inc. 35 AKRO	5,375.03	Jan. 14, 2025	USD 21.87	-3.36%	United States
36	NET Power Inc. 36 NPWR	5,297.49	Jan. 14, 2025	USD 8.80	-3.93%	United States
37	Zentek Ltd. 37 ZEN.V	4,907.32	Jan. 14, 2025	USD 1.04	3.69%	Canada
38	Lipum AB (publ) 38 LIPUM.ST	4,733.10	Jan. 14, 2025	USD 1.17	-3.73%	Sweden
39	Rezolute, Inc. 39 RZLT	4,715.37	Jan. 14, 2025	USD 4.72	-0.63%	United States
40	ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 40 1541.HK	4,673.89	Jan. 14, 2025	USD 0.62	4.32%	China
41	Viridian Therapeutics, Inc. 41 VRDN	4,422.27	Jan. 14, 2025	USD 16.86	-5.12%	United States
42	Eve Holding, Inc. 42 EVEX	4,146.45	Jan. 14, 2025	USD 4.20	-3.45%	United States
43	Carbios SAS 43 ALCRB.PA	4,085.55	Jan. 14, 2025	USD 6.44	-3.56%	France
44	Gaxos.ai Inc. 44 GXAI	3,974.19	Jan. 14, 2025	USD 1.71	2.40%	United States
45	Context Therapeutics Inc. 45 CNTX	3,918.10	Jan. 14, 2025	USD 0.99	-3.87%	United States
46	Tenax Therapeutics, Inc. 46 TENX	3,785.72	Jan. 14, 2025	USD 6.43	4.38%	United States
47	VirnetX Holding Corp 47 VHC	3,579.95	Jan. 14, 2025	USD 7.68	6.22%	United States
48	Chalice Mining Limited 48 CHN.AX	3,489.80	Jan. 14, 2025	USD 0.67	2.13%	Australia
49	PT Maha Properti Indonesia Tbk 49 MPRO.JK	3,409.54	Jan. 14, 2025	USD 0.12	-0.02%	Indonesia
50	Checkpoint Therapeutics, Inc. 50 CKPT	3,293.60	Jan. 14, 2025	USD 3.17	-0.94%	United States

1 2 3 4 … 449

Frequently Asked Questions

Which company has the highest Price to Sales Ratio (P/S) ?

The company with the highest Price to Sales Ratio (P/S) is Inhibikase Therapeutics, Inc. (NasdaqCM: IKT) at 184,503,984.00.
Which company has the lowest Price to Sales Ratio (P/S) ?

The company with the lowest Price to Sales Ratio (P/S) is LM Funding America, Inc. (NasdaqCM: LMFA) at 0.00.

What are the top 10 companies by Price to Sales Ratio (P/S) ?

The top 10 companies the Global by Price to Sales Ratio (P/S) are Inhibikase Therapeutics, Inc., Molecure S.A., De Grey Mining Limited, Genomtec S.A., Gatos Silver, Inc., Deep Yellow Limited, LQwD FinTech Corp., BrightPath Biotherapeutics Co., Ltd., NanoGroup S.A. and Benitec Biopharma Inc..
What are the bottom 10 companies by Price to Sales Ratio (P/S) ?

The bottom 10 companies by Price to Sales Ratio (P/S) are LM Funding America, Inc., Comtech Telecommunications Corp., Tennessee Valley Authority PARRS D 2028, Air Industries Group, Snail, Inc. Class A Common Stock, Streamline Health Solutions, Inc., Compuage Infocom Limited, Ispire Technology Inc., Grupo Casas Bahia S.A. and C-Lab Ltd.